Phibro Animal Health Corporation Completes Acquisition of Zoetis Pharmaceutical Feed Additive Product Portfolio and Certain Water-Soluble Products – Arterial Network

TEANECK, N.J.–(BUSINESS WIRE)–Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the successful completion of the acquisition of the medicated feed additive product portfolio and certain water-soluble products from Zoetis Inc. (NYSE:ZTS). This acquisition marks a significant step in furthering Phibro’s purpose to optimize global animal health and nutrition for better lives and a more sustainable world..

TEANECK, N.J. (BUSINESS NEWSLET) — Phibro Animal Health Corporation (NASDAQ: PAHC) today announced the successful completion of its acquisition of Zoetis Inc.’s (NYSE: ZTS) pharmaceutical feed additive product portfolio and certain Purchase of some water-soluble products. The acquisition marks an important step further in Phibro’s goal of optimizing animal health and nutrition globally for better lives and a more sustainable world. .

“Adding this new lineup of medicated feed additives and water-soluble products across cattle, swine and poultry will complement and expand Phibro’s species and product portfolios, helping customers meet the highest standards of animal care, prevent disease, and enhance nutrition around the world,” said Jack C.

“The addition of this new line of medicated feed additives and water-soluble products in cattle, swine and poultry will complement and expand Phibro’s species and product portfolio, helping customers achieve the highest standards of animal care, prevent disease, and enhance nutrition around the world, “Jack C.

Bendheim, Chairman, President and Chief Executive Officer of Phibro Animal Health Corporation. “These products fit Phibro’s core competencies and capabilities while complementing our current lineup of vaccines, nutritional specialties and mineral nutrition.”.

Bendheim, chairman, president and chief executive officer of Phibro Animal Health Corporation. “These products align with Phibro’s core competencies and capabilities while complementing our current vaccine, nutritional specialty and mineral nutritional products.”

The acquisition includes a product portfolio with more than 37 product lines sold across approximately 80 countries, six manufacturing sites in the U.S., Italy and China, and a team of more than 300 employees who primarily support the manufacturing and distribution activities of the business. The agreement to acquire the business was announced on April 28, 2024..

The acquisition includes a product portfolio with more than 37 product lines sold in approximately 80 countries, six production sites in the United States, Italy and China, and a team of more than 300 employees who primarily support the business’ Manufacturing and distribution activities. The agreement to acquire the company was announced on April 28, 2024. .

The portfolio is expected to boost Phibro’s profitability and EBITDA margin and be accretive to its Adjusted Earnings Per Share. Additional financial details will be provided during our Q1 earning call on November 7th.

The portfolio is expected to improve Phibro’s profitability and EBITDA margins and increase its adjusted earnings per share. We will provide more financial details during our first-quarter earnings call on November 7.

“This is a win-win-win,” noted Larry Miller, Phibro’s Chief Operating Officer. “For our customers, it broadens the solution options and expertise that Phibro brings to support animal health globally; for consumers, it helps continue to ensure that food is produced safely and sustainably; and for our investors, it expands and diversifies our revenue base, ultimately generating funding to support future investment in additional fast-growing animal health product categories.”.

“It’s a win-win,” said Phibro Chief Operating Officer Larry Miller. “For our customers, it broadens the solution options and expertise Phibro brings to support animal health worldwide; for consumers, it helps continue to ensure safe and sustainable food production; and for us For investors, it broadens and diversifies our revenue base, ultimately generating capital to support future investments in other fast-growing animal health product categories.”

About Phibro Animal Health Corporation

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals.

Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner to livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals, providing them with solutions that help maintain and enhance animal health.

For further information, please visit www.pahc.com..

For more information, please visit www.pahc.com. .

Forward-Looking Statements

forward-looking statements

DISCLOSURE NOTICES

Disclosure Notice

Forward-Looking Statements: This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this communication are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business.

Forward-Looking Statements: This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact contained in this communication are forward-looking statements. Forward-looking statements discuss our current expectations and projections regarding our financial condition, results of operations, plans, objectives, future performance and business.

You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “may,” “could,” “would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events.

You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “target,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “forecast,” “plan,” ” Words such as “intend”, “seek”, “could”, “might”, “would”, “would”, “should”, “could”, “might”, “could”, “negative”, etc., as well as those related to future operations or Other words and terms related to the timing or nature of financial results or other events.

These statements are not guarantees of future performance or actions. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made.

. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove incorrect, actual results may differ materially from those anticipated by the forward-looking statements. Forward-looking statements speak only as of the date they are made.

Phibro expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Quarterly Report on Form 10-Q and Annual Report on Form 10-K, including in the sections thereof captioned “Forward-Looking Statements” and “Risk Factors.” These filings an.

Phibro expressly disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. For a further list and description of risks, uncertainties and other matters, please see our Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, including the sections titled “Forward-Looking Statements” and “Risk Factors” therein. these files.

Internet Posting of Information: We routinely post information that may be important to investors in the “Investors” section of our website at www.pahc.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Internet Information Release: We regularly publish information that may be important to investors in the “Investors” section of our website www.pahc.com. We encourage investors and potential investors to regularly consult our website for important information about us.